Zymeworks (ZYME) Capital Expenditures (2021 - 2026)
Zymeworks' Capital Expenditures came in at $216,000 for Q1 2026, compared with $16,000 a year earlier and down 62.8% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Capital Expenditures (2021 - 2026) Analysis & Trends
For FY2025, Zymeworks' Capital Expenditures was $1.52 million, down 23.6% from FY2024.
- Capital Expenditures has declined in each of the last four years, with a five-year compound annual growth rate of -18.8% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.99 million in FY2024 (-19.5%), $2.47 million in FY2023 (-69.6%), $8.15 million in FY2022 (-34.3%) and $12.4 million in FY2021 (+187.8%).
- The five-year range for quarterly Capital Expenditures is $16,000 (Q1 2025) to $4.78 million (Q4 2021).
- Year-over-year, Capital Expenditures increased in 1 of the last seven quarters, with an average decline of 16.5%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2025 (growth of 85.0%), and the weakest in Q4 2022 (a decline of 92.7%).
- Business Quant data shows ZYME's Capital Expenditures at $581,000 (Q4 2025), $410,000 (Q3 2025) and $514,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Zymeworks | 1.94 Bn | 820.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Sep 30, 2024 | 899,000.00 |
| Jun 30, 2024 | 593,000.00 |
| Mar 31, 2024 | 185,000.00 |
| Dec 31, 2023 | 356,000.00 |
| Sep 30, 2023 | 930,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Dec 31, 2022 | 348,000.00 |
| Sep 30, 2022 | 981,000.00 |
| Jun 30, 2022 | 2.66 Mn |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | 4.78 Mn |
API Access
Zymeworks Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();